Literature DB >> 23630214

Treatment of metastatic colon cancer: "the times they are A-changing".

Nancy E Kemeny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23630214     DOI： 10.1200/JCO.2013.49.4500

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  Hospital academic status and value of care for nonmetastatic colon cancer.

Authors:  Christine M Veenstra; Andrew J Epstein; Kaijun Liao; Jennifer J Griggs; Craig E Pollack; Katrina Armstrong
Journal:  J Oncol Pract       Date:  2015-04-21       Impact factor: 3.840

2.  The effect of care setting in the delivery of high-value colon cancer care.

Authors:  Christine M Veenstra; Andrew J Epstein; Kaijun Liao; Arden M Morris; Craig E Pollack; Katrina A Armstrong
Journal:  Cancer       Date:  2014-06-20       Impact factor: 6.860

3.  Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.

Authors:  Kelsey Lau-Min; Preeti Prakash; Eunji Jo; Aaron P Thrift; Susan Hilsenbeck; Benjamin L Musher
Journal:  Clin Colorectal Cancer       Date:  2020-01-02       Impact factor: 4.481

4.  MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a.

Authors:  Jiaojiao Zhou; Mengwen Zhang; Yanqing Huang; Lin Feng; Hailong Chen; Yiwang Hu; Huarong Chen; Kaitai Zhang; Lei Zheng; Shu Zheng
Journal:  Cancer Lett       Date:  2014-10-16       Impact factor: 8.679

5.  Liver-directed conversion therapy in metastatic colon cancer.

Authors:  Alexandra Snyder; Nancy Kemeny; Ali Shamseddine; Ashwaq Al-Olayan; Fadi El-Merhi; David P Kelsen; Faek Jamali; Mustafa Sidani; Deborah Mukherji; Mahmoud El-Naghy; Eileen M O'Reilly; Leonard B Saltz; Ghassan K Abou-Alfa
Journal:  J Gastrointest Oncol       Date:  2015-06

6.  Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.

Authors:  Timothy L Frankel; Efsevia Vakiani; Hari Nathan; Ronald P DeMatteo; T Peter Kingham; Peter J Allen; William R Jarnagin; Nancy E Kemeny; David B Solit; Michael I D'Angelica
Journal:  Cancer       Date:  2016-10-13       Impact factor: 6.860

Review 7.  TroVax in colorectal cancer.

Authors:  Julie Rowe; Putao Cen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan.

Authors:  Bryan K Kee; Jeffrey S Morris; Rebecca S Slack; Todd Crocenzi; Lucas Wong; Ben Esparaz; Michael Overman; Katrina Glover; Desiree Jones; Sijin Wen; Michael J Fisch
Journal:  Support Care Cancer       Date:  2014-08-27       Impact factor: 3.603

Review 9.  Intraarterial Chemotherapy for Liver Metastases.

Authors:  Louise C Connell; Nancy E Kemeny
Journal:  Surg Oncol Clin N Am       Date:  2020-10-20       Impact factor: 3.495

10.  pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer.

Authors:  Dan-Li Hao; Ran Xie; Ge-Jing De; Hong Yi; Chen Zang; Mi-Yi Yang; Li Liu; Hai Ma; Wei-Yan Cai; Qing-He Zhao; Feng Sui; Yan-Jun Chen
Journal:  Int J Nanomedicine       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.